Urokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA mediates its action while attached to a membrane-bound receptor (uPAR). In this investigation we show that uPAR levels correlate with uPA levels in human breast cancers. uPAR levels, however, d
Blood urokinase plasminogen activator system in chronic urticaria
β Scribed by Alicja Kasperska-Zajac; Zenon Brzoza; Barbara Rogala
- Book ID
- 106078697
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 195 KB
- Volume
- 298
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.
The urokinase-type plasminogen activator (u-PA) system consists of the serine proteinases plasmin and u-PA; the serpin inhibitors a 2 -anti-plasmin, PAI-1 and PAI-2; and the u-PA receptor (u-PAR). Two lines of evidence have strongly suggested an important and apparently causal role for the u-PA syst
## Abstract The urokinase plasminogen activator (uPA) receptor (uPAR) is a GPIβlinked cell surface protein that facilitates focused plasmin proteolytic activity at the cell surface. uPAR has been detected in macrophages infiltrating the central nervous system (CNS) and soluble uPAR has been detecte